KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) Other Operating Expenses (2017 - 2025)

Guardant Health (GH) has disclosed Other Operating Expenses for 9 consecutive years, with $242.9 million as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses rose 33.19% to $242.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $843.7 million through Dec 2025, up 28.86% year-over-year, with the annual reading at $843.7 million for FY2025, 28.86% up from the prior year.
  • Other Operating Expenses hit $242.9 million in Q4 2025 for Guardant Health, up from $221.0 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $242.9 million in Q4 2025 to a low of $63.1 million in Q1 2021.
  • Historically, Other Operating Expenses has averaged $143.8 million across 5 years, with a median of $128.9 million in 2022.
  • Biggest five-year swings in Other Operating Expenses: soared 75.11% in 2021 and later decreased 18.97% in 2024.
  • Year by year, Other Operating Expenses stood at $93.0 million in 2021, then surged by 38.19% to $128.5 million in 2022, then soared by 75.07% to $225.0 million in 2023, then decreased by 18.97% to $182.4 million in 2024, then soared by 33.19% to $242.9 million in 2025.
  • Business Quant data shows Other Operating Expenses for GH at $242.9 million in Q4 2025, $221.0 million in Q3 2025, and $200.8 million in Q2 2025.